TECON(SZ:002100) Zheng Quan Zhi Xing·2025-08-25 16:35Core Viewpoint - TianKang Biological Co., Ltd. plans to acquire 51% equity of Xinjiang Qiangdu Animal Husbandry Technology Co., Ltd. through cash payment, aiming to gain control over the target company [1][3] Transaction Overview - The acquisition framework agreement was signed on August 25, 2025, between TianKang Biological, Qiangdu Animal Husbandry, and its controlling shareholder, Qixing Qiangdu Group [3] - The agreement is preliminary and subject to due diligence, auditing, and evaluation, with the final transaction details to be determined in a formal agreement [2][3] - The transaction is not expected to constitute a major asset restructuring as per relevant regulations, nor will it involve issuing shares or changing control of the company [2][3] Parties Involved - TianKang Biological is the acquirer, while Qixing Qiangdu Group is the controlling shareholder of Qiangdu Animal Husbandry, holding 83.3564% of its equity [6][7] - The actual control of Qiangdu Animal Husbandry is held by Xu Songjiang and Xu Min, who collectively control 97.4890% of the company [6][7] Transaction Details - The agreement stipulates that Qixing Qiangdu Group will coordinate with other shareholders to transfer a total of 51% equity to TianKang Biological [8] - The final transaction price will be based on evaluations conducted by qualified asset appraisal institutions [8] - The agreement includes a exclusivity clause preventing parties from negotiating similar transactions with third parties [9] Impact on the Company - The acquisition aligns with TianKang Biological's strategic goals and is expected to enhance its market share in the pig farming industry [10] - Qiangdu Animal Husbandry operates a complete pig farming industry chain, which is significant for the local livestock sector [10] - The transaction is anticipated to strengthen the company's overall competitiveness and support its long-term development in the Xinjiang region [10]